Slendacor® Weight Management Complex Granted Patent for Research on Thermogenic Benefits
MORRISTOWN, N.J., Jan. 8, 2024 /PRNewswire/ -- PLT Health Solutions, Inc. announced that Slendacor® Weight Management Complex has added to its intellectual property portfolio with a recently granted patent related to new clinical work that studied mechanisms of action behind its weight loss and body shaping benefits, and which demonstrated thermogenic benefits. The invention cited in the patent relates to Slendacor's ability to increase lean body mass and accelerate the conversion of white adipose tissue to the more metabolically active brown or 'beige' adipose tissue. The Japanese patent was part of a global patent initiative by PLT and innovation partner Laila Nutraceuticals and is the first country patent granted as part of a PCT filing across multiple markets. Slendacor is also marketed as Slimvance® in select markets.
- MORRISTOWN, N.J., Jan. 8, 2024 /PRNewswire/ -- PLT Health Solutions, Inc. announced that Slendacor® Weight Management Complex has added to its intellectual property portfolio with a recently granted patent related to new clinical work that studied mechanisms of action behind its weight loss and body shaping benefits, and which demonstrated thermogenic benefits.
- The Japanese patent was part of a global patent initiative by PLT and innovation partner Laila Nutraceuticals and is the first country patent granted as part of a PCT filing across multiple markets.
- Our customers can be confident of the groundbreaking benefits and efficacy they can offer consumers with Slendacor," he added.
- Consistent body weight reductions were observed throughout the 16-week trial – starting with statistically significant weight loss at two weeks.